IRIS
GIANNANTONI, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.517
EU - Europa 19.687
AS - Asia 12.106
SA - Sud America 3.708
Continente sconosciuto - Info sul continente non disponibili 1.271
AF - Africa 634
OC - Oceania 68
Totale 68.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.150
SG - Singapore 4.389
CN - Cina 3.961
IT - Italia 3.765
GB - Regno Unito 3.259
BR - Brasile 3.135
IE - Irlanda 3.055
RU - Federazione Russa 2.779
FR - Francia 2.435
UA - Ucraina 2.271
HK - Hong Kong 1.269
VN - Vietnam 1.255
SE - Svezia 1.131
NG - Nigeria 355
FI - Finlandia 315
DE - Germania 282
AR - Argentina 212
BD - Bangladesh 200
IN - India 190
CA - Canada 182
NL - Olanda 131
TR - Turchia 124
ID - Indonesia 113
IQ - Iraq 109
EC - Ecuador 105
ZA - Sudafrica 105
MX - Messico 81
AU - Australia 63
KR - Corea 61
PK - Pakistan 61
CO - Colombia 56
JP - Giappone 50
VE - Venezuela 49
MY - Malesia 48
SA - Arabia Saudita 48
CL - Cile 47
MA - Marocco 47
EU - Europa 46
PY - Paraguay 42
AT - Austria 41
UZ - Uzbekistan 36
PL - Polonia 28
PE - Perù 27
RO - Romania 27
EG - Egitto 26
KE - Kenya 26
AE - Emirati Arabi Uniti 25
UY - Uruguay 24
ES - Italia 23
RS - Serbia 22
BE - Belgio 21
JO - Giordania 21
KZ - Kazakistan 18
OM - Oman 18
TN - Tunisia 16
BG - Bulgaria 15
CH - Svizzera 15
DZ - Algeria 15
JM - Giamaica 15
NP - Nepal 15
AZ - Azerbaigian 14
CR - Costa Rica 13
IL - Israele 13
BZ - Belize 12
BO - Bolivia 11
CI - Costa d'Avorio 11
DO - Repubblica Dominicana 11
TT - Trinidad e Tobago 11
AL - Albania 10
HN - Honduras 10
AO - Angola 9
LB - Libano 9
SV - El Salvador 9
GR - Grecia 8
IR - Iran 8
BY - Bielorussia 7
IM - Isola di Man 7
AM - Armenia 6
SN - Senegal 6
GE - Georgia 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
PH - Filippine 5
SY - Repubblica araba siriana 5
BB - Barbados 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
HR - Croazia 4
PA - Panama 4
TH - Thailandia 4
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MD - Moldavia 3
MK - Macedonia 3
NI - Nicaragua 3
PR - Porto Rico 3
QA - Qatar 3
Totale 67.714
Salva come PNG Salva come JPEG
Città #
Dallas 10.097
Dublin 2.973
Southend 2.970
Jacksonville 2.528
Fairfield 2.289
Singapore 1.774
Milan 1.369
Hong Kong 1.255
Ashburn 1.191
Chandler 1.191
Princeton 1.019
Woodbridge 1.016
Wilmington 990
Seattle 849
Beijing 816
Houston 799
Cambridge 779
The Dalles 691
Nanjing 683
Santa Clara 585
San Mateo 512
Rome 506
Moscow 485
Lauterbourg 449
Ho Chi Minh City 437
Abuja 353
Council Bluffs 323
Ann Arbor 308
Helsinki 294
San Jose 275
Columbus 273
Hanoi 266
Los Angeles 241
Boardman 235
Buffalo 226
Nanchang 225
Redondo Beach 223
New York 222
São Paulo 219
San Diego 206
Figino 176
Siena 155
Dearborn 154
Shenyang 151
Changsha 136
Tianjin 133
Hebei 119
Turin 99
Hefei 98
Jiaxing 94
Shanghai 87
Toronto 85
Rio de Janeiro 84
San Francisco 84
Norwalk 76
Kunming 72
Belo Horizonte 69
London 65
Da Nang 62
Naples 62
Izmir 60
Seoul 59
Bologna 58
Frankfurt am Main 56
Haiphong 56
Johannesburg 53
Curitiba 52
Guangzhou 51
Orem 51
Dhaka 49
Chicago 48
Porto Alegre 48
Palermo 45
Guarulhos 43
Tokyo 43
Brasília 42
Florence 40
Amsterdam 38
Brooklyn 37
Salvador 37
Zhengzhou 37
Munich 35
Baghdad 34
Sydney 34
Kuala Lumpur 33
Vienna 33
Jinan 32
Bari 31
Quito 31
Ribeirão Preto 31
Campinas 30
Santo André 30
Boston 29
Goiânia 29
Guayaquil 29
Genoa 28
Lanzhou 28
Manchester 28
Sorocaba 28
Tashkent 28
Totale 45.787
Salva come PNG Salva come JPEG
Nome #
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 7.631
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 487
Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup 294
Utilizzo degli Alfa-litici nelle donne con sintomi del basso tratto urinario 294
Urinary and bowel disfunction in autism spectrum disorder: a prospective, observational study 291
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 264
Urodynamic findings and functional outcomes after laparoscopic sacrocolpopexy for symptomatic pelvic organ prolapse 241
A Camey II Modified Neobladder: Long-Term Complications And Functional Results 238
A Camey II Modified Neobladder: Long-Term Complications And Functional Results 215
Pharmacologic goals in interstitial cystitis/bladder pain syndrome 208
"Voiding dysfunction in post-comatose patients" 198
Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: A clinical algorithm from an Italian consensus statement 197
"Advanced analysis in the pressure flow-study: a comparison of methods". 190
Food-Specific IgG4 Antibody-Guided Exclusion Diet Improves Conditions of Patients with Chronic Pain 189
Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial 185
"PSYCHOLOGICAL INVESTIGATION AND SEXUAL DYSFUNCTION IN SPINAL CORD INJURY WOMEN 184
"Psychological investigation and sexual dysfunction in spinal cord injury women". 184
The impact of Mirabegron on sexual function in women with idiopathic overactive bladder 183
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer 181
"Comparison of cystometric patterns in spinal cord injury and multiple sclerosis patients" 180
"Continuous ambulatory urodynamic monitoring: its role in diagnosing female micturitional disorders" 179
"In vitro study of passive vs electromotive mitomycin C diffusion in human bladder wall. Preliminary results". 179
"Clean intermittent catheterization prevents upper urinary tract disease in long-term spinal cord injured (SCJ) patients" 179
"Valutazione neuro-urologica ed endoscopica ed attuali orientamenti terapeutici" 178
"Anal sphincterometry: is it a good alternative to perineal floor EMG recordings?." 178
Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: a pilot study 178
Usefulness of antibiotic prophylaxis in invasive urodynamics in fertile and in postmenopausal female subjects 177
"Neurological features and urological dysfunction in survivors from prolonged coma". 176
"In reply to Dr Silver" 175
"Intravesical Capsaicin in the treatment of hyperactive bladder in Spinal Cord injury (SCI) patients". 174
Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder 173
"Vesciche ileali di sostituzione: studio morfo-funzionale" 173
Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence 173
Single-session supine bilateral percutaneous nephrolithotomy 171
Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence 169
An Updated Systematic Review and Statistical Comparison of Standardised Mean Outcomes for the Use of Botulinum Toxin in the Management of Lower Urinary Tract Disorders 169
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease 168
Endoscopic ballistic lithotripsy in the treatment of Bladder Calculi in patients with Neurogenic Voiding Dysfunction 167
Dyssynergia or asynergia? 167
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 166
Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System 164
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis 163
Assessment of botulinum A toxin high affinity SV2 receptors on normal human urothelial cells. 162
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 162
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 161
Bladder and urethral sphincter function after radical retropubic prostatectomy: A prospective long-term study 161
Intravesical resiniferatoxin versus capsaicin in the treatment of detrusor hypereflexia in spinal cord injured patients 160
Resonance® metallic stent in patients with ureterocutaneostomies 159
Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study 158
"Management of functional voiding dysfunction in children by means of voiding biofeedback" 158
"The Nocturnal alarm as a conditioning therapy in primary nocturnal enuresis" 157
Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder 156
Urgency of micturition and detrusor contractility in men with prostatic obstruction and overactive bladders 156
Two-year efficacy and safety of botulinum A toxin intravesical injections in patients affected by refractory painful bladder syndrome 156
Sequential intravesical bacillus Calmette-Guerin and electromotive mitomycin-C for high risk superficial bladder cancer: a prospective controlled study 155
Dermatomyositis Associated with Testicular Germ Cell Cancer 154
New frontiers in intravesical therapies and drug delivery 153
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis 153
Thalidomide as therapy for the chronic pelvic pain syndrome (CPPS) 153
“Efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by Multiple Sclerosis: Long term follow up” 153
Botulinum A toxin intravesical injections improves sexual function in female patients affected by neurogenic detrusor overactivity 153
Prostasomes and prostate cancer 152
PUMA vs Romanzi in the detection of female bladder obstruction and detrusor contractility. 152
Clinical and neurophysiologic study of botulinum A toxin effect on neurogenic and idiopathic detrusor overactivity 151
Stability of Resiniferatoxin stock solutions 150
Long-term efficacy of the trans-obturator and retropubic mid-urethral slings for stress urinary incontinence: update from a randomized clinical trial 150
Six-year follow-up of intradetrusorial injections of botulinum toxin type A in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results 149
Does the neobladder filling modulate soleus H reflex? 149
Must colposuspension be associated with sacropexy to prevent postoperative urinary incontinence? 149
Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study) 149
Editorial comment on: Complete continence after botulinum neurotoxin type a injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks 148
Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study 147
Botulinum A toxin modulates afferent fibers in neurogenic detrusor overactivity 147
Patient-reported outcomes in bladder pain syndrome: qui auget dolorem, auget et scientiam (as pain increases, so increases knowledge) 146
Thalidomide as therapy for the chronic pelvic pain syndrome (CPPS) 146
Intravesical administration of botulinum A toxin in spinal cord injured patients. Suburothelial versus intradetrusorial injections 146
Autonomic dysreflexia during urodynamics 146
Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group 145
Voiding dysfunction after radical retropubic prostatectomy: More than external urethral sphincter deficiency 145
Botulinum toxin a enters normal human urothelial cells and modulates the sensory activity of bladder urothelium 145
Triage of functional, female and neuro-urology patients during and immediately after the COVID-19 outbreak 145
Preoperative MUCP and VLPP Did Not Predict Long-Term (4-Year) Outcome after Transobturator Mid-Urethral Sling 144
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis 144
A prospective randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease 144
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 144
Is the one-hour pad-test useful in the assessment of urinary stress incontinence? 144
Treatment of neurogenic bladder in spinal cord injury (SCI) patients by means of clean intermittent catheterization (CIC): prevention of renal disease 144
Urologic dysfunction and neurologic outcome in coma survivors after severe traumatic brain injury in the postacute and chronic phase 144
Tension-free vaginal tape (TVT) and trans-obturator suburethral tape (TOT) a prospective randomized trial 144
Intravesical resiniferatoxin versus botulinum-A toxin injections in patients with neurogenic detrusor overactivity: a prospective randomized study 144
The Efficacy and Safety of Duloxetine in a Multidrug Regimen for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 144
Diagnosi di ipermobilità uretrale mediante q-Tip vs ecografia 143
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study 143
Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity 143
NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND DETRUSOR OVER ACTIVITY TREATED WITH TAMSULOSIN 142
Hypospadias classification and repair: the riddle of the sphinx 142
Comparative bladder wall tissue levels of resiniferatoxin 142
Linking age, cystocele and abdominal straining 142
Multicenter, randomized, phase III trial comparing radical retropubic prostatectomy with conventional external beam radiotherapy for localized prostate cancer: An interim report 142
Female sexuality in chronic pelvic pain 142
Totale 24.488
Salva come PNG Salva come JPEG
Categoria #
all - tutte 214.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 214.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.480 0 459 556 377 31 133 66 254 187 591 342 1.484
2022/20236.043 542 162 961 1.178 549 1.433 60 360 532 67 115 84
2023/20243.317 152 87 273 92 83 990 1.130 56 20 87 54 293
2024/20257.999 202 708 284 565 527 189 78 349 901 640 1.292 2.264
2025/202627.316 1.257 4.721 7.603 2.729 2.638 800 2.189 781 788 909 440 2.461
2026/20271.496 1.260 236 0 0 0 0 0 0 0 0 0 0
Totale 68.991